Technology area: Semiconductors, Circuits & Optics
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
The National Institute Of Health And Medical Research (Inserm) currently manages 1 pending office action within the Semiconductors, Circuits & Optics technology area. This action is being handled by 1 distinct examiner, LAGUARDA, GONZALO. The concentration of work under 1 distinct art unit suggests a focused technical scope for this specific portion of the portfolio.
Because LAGUARDA, GONZALO is the busiest examiner with 1 pending action, the prosecution strategy remains centralized. Practitioners should note that with only 1 distinct examiner involved, the outcome of this pending matter will directly impact the success rate in this technology sector. The alignment of 1 pending office action with 1 distinct art unit indicates that the institute's current semiconductor research is being evaluated by a single specialized department.
For the legal team, the interaction with LAGUARDA, GONZALO represents the entirety of the current USPTO engagement. Navigating the specific requirements of this 1 distinct examiner is the primary task for advancing the portfolio. The lack of broader distribution across multiple examiners or art units simplifies the tracking of deadlines but increases the reliance on a single examiner's interpretation of the claims.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LAGUARDA, GONZALO | 1 | 73.1% | +7.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18869890 | COMPACT ULTRASOUND TRANSDUCERS FOR INTRAORAL USES | LAGUARDA, GONZALO | — |
| Art Unit | Apps |
|---|---|
| 2855 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18869890 | COMPACT ULTRASOUND TRANSDUCERS FOR INTRAORAL USES | LAGUARDA, GONZALO | 2855 | §102§103 | Non-Final OA | — | Pending | Nov 27, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNational Institute Of Health And Medical Research (Inserm) has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Gonzalo Laguarda has the most, with 1 of National Institute Of Health And Medical Research (Inserm)'s pending office actions.
Mostly Semiconductors, Circuits & Optics (USPTO Tech Center 2800), based on where its pending office actions are examined.